<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000390301"><TermName>motexafin lutetium</TermName><TermPronunciation>(moh-TEK-suh-fin loo-TEE-shee-um)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer using photodynamic therapy. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731343" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;motexafin lutetium&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731342" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;motexafin lutetium&quot;" language="es" id="_4"/><SpanishTermName>motexafin lutetium</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer en que se usa la terapia fotodinámica. Es un tipo de metalotexaferina. También se llama lutetium texaphyrin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-10-25</DateFirstPublished><DateLastModified>2004-10-21</DateLastModified></GlossaryTerm>
